Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Humana Inc. buy Mizuho

Start price
€333.00
26.01.24 / 50%
Target price
€368.28
26.01.25
Performance (%)
-14.74%
Price
€283.10
30.04.24
Summary
This prediction is currently active. The price of Humana Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.74%. Dividends of €0.82 are taken into consideration when calculating the performance. This prediction currently runs until 26.01.25. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this prediction

Humana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.

Performance without dividends (%)
Name 1w 1m
Humana Inc. -7.367% -7.367%
iShares Core DAX® 0.961% -2.210%
iShares Nasdaq 100 2.626% -1.918%
iShares Nikkei 225® 0.217% -7.216%
iShares S&P 500 1.540% -1.858%

Comments by Mizuho for this prediction

In the thread Humana Inc. diskutieren
Prediction Buy
Perf. (%) -14.74%
Target price 368.280
Change
Ends at 26.01.25

Humana Inc. (NYSE: HUM) had its price target lowered by analysts at Mizuho from $550.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for HUM provided by MarketBeat